578 related articles for article (PubMed ID: 20213245)
1. Thymoquinone from nutraceutical black cumin oil activates Neu4 sialidase in live macrophage, dendritic, and normal and type I sialidosis human fibroblast cells via GPCR Galphai proteins and matrix metalloproteinase-9.
Finlay TM; Jayanth P; Amith SR; Gilmour A; Guzzo C; Gee K; Beyaert R; Szewczuk MR
Glycoconj J; 2010 Apr; 27(3):329-48. PubMed ID: 20213245
[TBL] [Abstract][Full Text] [Related]
2. Thymoquinone-induced Neu4 sialidase activates NFκB in macrophage cells and pro-inflammatory cytokines in vivo.
Finlay TM; Abdulkhalek S; Gilmour A; Guzzo C; Jayanth P; Amith SR; Gee K; Beyaert R; Szewczuk MR
Glycoconj J; 2010 Aug; 27(6):583-600. PubMed ID: 20697956
[TBL] [Abstract][Full Text] [Related]
3. A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes.
Alghamdi F; Guo M; Abdulkhalek S; Crawford N; Amith SR; Szewczuk MR
Cell Signal; 2014 Jun; 26(6):1355-68. PubMed ID: 24583283
[TBL] [Abstract][Full Text] [Related]
4. Dependence of pathogen molecule-induced toll-like receptor activation and cell function on Neu1 sialidase.
Amith SR; Jayanth P; Franchuk S; Siddiqui S; Seyrantepe V; Gee K; Basta S; Beyaert R; Pshezhetsky AV; Szewczuk MR
Glycoconj J; 2009 Dec; 26(9):1197-212. PubMed ID: 19430901
[TBL] [Abstract][Full Text] [Related]
5. G-protein coupled receptor agonists mediate Neu1 sialidase and matrix metalloproteinase-9 cross-talk to induce transactivation of TOLL-like receptors and cellular signaling.
Abdulkhalek S; Guo M; Amith SR; Jayanth P; Szewczuk MR
Cell Signal; 2012 Nov; 24(11):2035-42. PubMed ID: 22759791
[TBL] [Abstract][Full Text] [Related]
6. Neu1 sialidase and matrix metalloproteinase-9 cross-talk regulates nucleic acid-induced endosomal TOLL-like receptor-7 and -9 activation, cellular signaling and pro-inflammatory responses.
Abdulkhalek S; Szewczuk MR
Cell Signal; 2013 Nov; 25(11):2093-105. PubMed ID: 23827939
[TBL] [Abstract][Full Text] [Related]
7. Detection of Neu1 sialidase activity in regulating Toll-like receptor activation.
Amith SR; Jayanth P; Finlay T; Franchuk S; Gilmour A; Abdulkhalek S; Szewczuk MR
J Vis Exp; 2010 Sep; (43):. PubMed ID: 20864924
[TBL] [Abstract][Full Text] [Related]
8. Biased G protein-coupled receptor agonism mediates Neu1 sialidase and matrix metalloproteinase-9 crosstalk to induce transactivation of insulin receptor signaling.
Haxho F; Haq S; Szewczuk MR
Cell Signal; 2018 Mar; 43():71-84. PubMed ID: 29277445
[TBL] [Abstract][Full Text] [Related]
9. Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for neurotrophin activation of Trk receptors and cellular signaling.
Jayanth P; Amith SR; Gee K; Szewczuk MR
Cell Signal; 2010 Aug; 22(8):1193-205. PubMed ID: 20347965
[TBL] [Abstract][Full Text] [Related]
10. A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer.
Gilmour AM; Abdulkhalek S; Cheng TS; Alghamdi F; Jayanth P; O'Shea LK; Geen O; Arvizu LA; Szewczuk MR
Cell Signal; 2013 Dec; 25(12):2587-603. PubMed ID: 23993964
[TBL] [Abstract][Full Text] [Related]
11. Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for Toll-like receptor activation and cellular signaling.
Abdulkhalek S; Amith SR; Franchuk SL; Jayanth P; Guo M; Finlay T; Gilmour A; Guzzo C; Gee K; Beyaert R; Szewczuk MR
J Biol Chem; 2011 Oct; 286(42):36532-49. PubMed ID: 21873432
[TBL] [Abstract][Full Text] [Related]
12. Dependence of neurotrophic factor activation of Trk tyrosine kinase receptors on cellular sialidase.
Woronowicz A; Amith SR; De Vusser K; Laroy W; Contreras R; Basta S; Szewczuk MR
Glycobiology; 2007 Jan; 17(1):10-24. PubMed ID: 16971381
[TBL] [Abstract][Full Text] [Related]
13. Neu4, a novel human lysosomal lumen sialidase, confers normal phenotype to sialidosis and galactosialidosis cells.
Seyrantepe V; Landry K; Trudel S; Hassan JA; Morales CR; Pshezhetsky AV
J Biol Chem; 2004 Aug; 279(35):37021-9. PubMed ID: 15213228
[TBL] [Abstract][Full Text] [Related]
14. Neu1 desialylation of sialyl alpha-2,3-linked beta-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling.
Amith SR; Jayanth P; Franchuk S; Finlay T; Seyrantepe V; Beyaert R; Pshezhetsky AV; Szewczuk MR
Cell Signal; 2010 Feb; 22(2):314-24. PubMed ID: 19796680
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of endogenous sialidases of human monocytes during cellular differentiation into macrophages.
Stamatos NM; Liang F; Nan X; Landry K; Cross AS; Wang LX; Pshezhetsky AV
FEBS J; 2005 May; 272(10):2545-56. PubMed ID: 15885103
[TBL] [Abstract][Full Text] [Related]
16. Ganglioside GM3 sialidase activity in fibroblasts of normal individuals and of patients with sialidosis and mucolipidosis IV. Subcellular distribution and and some properties.
Lieser M; Harms E; Kern H; Bach G; Cantz M
Biochem J; 1989 May; 260(1):69-74. PubMed ID: 2775195
[TBL] [Abstract][Full Text] [Related]
17. The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo.
Hyun SW; Liu A; Liu Z; Cross AS; Verceles AC; Magesh S; Kommagalla Y; Kona C; Ando H; Luzina IG; Atamas SP; Piepenbrink KH; Sundberg EJ; Guang W; Ishida H; Lillehoj EP; Goldblum SE
Glycobiology; 2016 Aug; 26(8):834-49. PubMed ID: 27226251
[TBL] [Abstract][Full Text] [Related]
18. Thymoquinone strongly inhibits fMLF-induced neutrophil functions and exhibits anti-inflammatory properties in vivo.
Boudiaf K; Hurtado-Nedelec M; Belambri SA; Marie JC; Derradji Y; Benboubetra M; El-Benna J; Dang PM
Biochem Pharmacol; 2016 Mar; 104():62-73. PubMed ID: 26774451
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of membrane-associated sialidase Neu3 decreases GD3 and increases GM3 on the surface of Jurkat cells during etoposide-induced apoptosis.
Azuma Y; Sato H; Higai K; Matsumoto K
Biol Pharm Bull; 2007 Sep; 30(9):1680-4. PubMed ID: 17827720
[TBL] [Abstract][Full Text] [Related]
20. Thymoquinone inhibits the migration of mouse neuroblastoma (Neuro-2a) cells by down-regulating MMP-2 and MMP-9.
Arumugam P; Subramanian R; Priyadharsini JV; Gopalswamy J
Chin J Nat Med; 2016 Dec; 14(12):904-912. PubMed ID: 28262117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
